Alkermes (ALKS) Return on Capital Employed Growth (3y) (2014 - 2026)
Alkermes (ALKS) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1,301.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 353.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 480.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 1,342.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 2,112.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 626.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1,788.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 4,862.00 |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn | 1,809.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 626.00 |
| Dec 31, 2025 | 1,404.00 |
| Sep 30, 2025 | 1,921.00 |
| Jun 30, 2025 | 1,934.00 |
| Mar 31, 2025 | 1,838.00 |
| Dec 31, 2024 | 1,929.00 |
| Sep 30, 2024 | 129.00 |
| Jun 30, 2024 | -40.00 |
| Mar 31, 2024 | 1,231.00 |
| Dec 31, 2023 | 1,074.00 |
| Sep 30, 2023 | 2,341.00 |
| Jun 30, 2023 | 1,966.00 |
| Mar 31, 2023 | -29.00 |
| Dec 31, 2022 | 135.00 |
| Sep 30, 2022 | 646.00 |
| Jun 30, 2022 | 782.00 |
| Mar 31, 2022 | 774.00 |
| Dec 31, 2021 | 744.00 |
| Sep 30, 2021 | 231.00 |
| Jun 30, 2021 | 299.00 |